Peter J. Williams
Nessuna posizione attualmente
Profilo
Peter J.
Williams worked as a Senior Director of Business Development at Millennium Pharmaceuticals from 1998 to 2004, and as a Senior Director of Business Development at Alnylam Pharmaceuticals from 2006 to 2009.
He then worked as an Associate Director at Harvard Medical School, followed by a Vice President of Business Development at ImmunoGen from 2009 to 2017.
Prior to that, he was a Vice President of Business Development at Link Medicine Corp.
in 2005.
Williams graduated from Imperial College London with a graduate degree and from the University of Sussex with an undergraduate degree.
Precedenti posizioni note di Peter J. Williams
| Società | Posizione | Fine |
|---|---|---|
| IMMUNOGEN, INC. | Corporate Officer/Principal | 01/12/2017 |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Link Medicine Corp.
 Link Medicine Corp. Pharmaceuticals: MajorHealth Technology Link Medicine Corp. develops disease modifying neurodegenerative therapies. The company was founded by Edward I. Rudman, Peter T. Lansbury, David Neafus and Adam J. Rosenberg in 2005 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2006 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2004 |
| Harvard Medical School | Corporate Officer/Principal | - |
Formazione di Peter J. Williams
| University of Sussex | Undergraduate Degree |
| Imperial College London | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| IMMUNOGEN, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Link Medicine Corp.
Link Medicine Corp. Pharmaceuticals: MajorHealth Technology Link Medicine Corp. develops disease modifying neurodegenerative therapies. The company was founded by Edward I. Rudman, Peter T. Lansbury, David Neafus and Adam J. Rosenberg in 2005 and is headquartered in Cambridge, MA. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Peter J. Williams
